Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Organ-on-a-Chip and 3D-Culture: Companies, Technologies and Approaches

Organ-on-a-Chip and 3D-Culture: Companies, Technologies and Approaches

Date: Monday, 10 July 2017 - Tuesday, 11 July 2017
Location: Boston, USA


Moderator

Emma Sceats

Emma Sceats
Chief Executive Officer, CN Bio Innovations Ltd.

Keynote Speakers

Michael Shuler

Michael Shuler
Samuel B. Eckert Professor of Engineering, Cornell University; President & CEO, Hesperos, Inc.

John Wikswo

John Wikswo
A.B. Learned Professor of Living State Physics; Founding Director, Vanderbilt Institute for Integrative Biosystems, Vanderbilt University

James Hickman

James Hickman
Professor, University of Central Florida

Tommy Andersson

Tommy Andersson
Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Mölndal

Linda Griffith

Linda Griffith
Professor, Massachusetts Institute of Technology (MIT)

Katia Karalis

Katia Karalis
Executive Vice President of Research, Emulate, Inc.

Roger Kamm

Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

Overview

Select Biosciences Third Annual Organ-on-a-Chip World Congress 2017 focuses on an important and expanding field wherein cells are being assembled using Microfluidics and Lab-on-a-Chip technologies in a functionally-relevant manner.  These clusters of "assembled cells" have functional significance and can mimic in vivo organ structure.

Liver cells assembled on-board chips in a physiologically-relevant architecture using microfluidics can, for instance, be utilized for toxicity screening and the ability to assemble organ fragments ex vivo can provide an exquisite means to reconstruct biological processes (both physiological and pathological) "in a dish" or "on a chip."  A number of chips such Lung-on-a-Chip, Brain-on-a-Chip, Gut-on-a-Chip, Marrow-on-a-Chip, Bone-on-a-Chip, Nerve-on-a-Chip amongst others have been built and will be presented and explored at this conference. We will also focus on "disease-on-a-chip", cancer-on-a-chip, immune system-on-a-chip.

Due to the Overlap of this Topic with 3D-Culture and Stem Cells in Drug Discovery, the co-located concurrent parallel conference tracks focus on these topics thereby offering complete coverage of these related fields to the conference delegates.

Major Themes Addressed in the 3D-Culture Conference:
  • Using 3D-cultures as a tool for screening in the oncology space in a physiologically-relevant context
  • Studies of drug metabolism and the cytochrome P450 pathway facilitated in a physiologically-relevant context
The Three Conference Tracks are Co-Located and Concurrent and Delegates can Participate, Mix-and-Match Presentations and Network Extensively with their Colleagues from all 3 Conference Tracks. The Exhibit hall is co-located and is accessible by delegates from all 3 conference tracks.

Co-Located, Concurrent Conference Tracks:
  • Organ-on-a-Chip World Congress 2017
  • 3D-Culture 2017
  • Stem Cells in Drug Discovery & Toxicity Screening 2017
All the Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.
Session Sponsors

Agenda Topics

  • 3D-Culture in Liver Toxicity Screening
    • Cytochrome P450 Screening Assays
    • Liver Biology and Drug Toxicity Screening
  • 3D-Culture of Cells as a Means for Physiological Cellular Culture
  • 3D-Culture of Cells: Drivers and Approaches
  • 3D-Microtissues
  • Microscopy, High-Content Screening and 3D-Culture
  • Neurospheres
  • Using 3D-Cultures as a Tool for Screening in the Oncology Field

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Tania Konry, Assistant Professor, Department of Pharmaceutical Sciences, Northeastern University
Ashutosh Agarwal, Assistant Professor, Department of Biomedical Engineering, University of Miami Miller School of Medicine
Ayesha Arefin, Researcher, University of New Mexico
Holger Becker, Chief Scientific Officer, Microfluidic ChipShop GmbH
Herman Blok, Business Development Manager, Micronit Microtechnologies
Joseph L Charest, Program Manager, Charles Stark Draper Laboratory
Thomas Corso, Chief Technical Officer, CorSolutions
Brad Dykstra, Senior Research Scientist, Platelet BioGenesis; Brigham and Women’s Hospital and Harvard Medical School
Olivier Frey, Product Manager Microphysiological Systems, InSphero AG, Schlieren, Switzerland
William Gray, Professor of Functional Neurosurgery, Cardiff University School of Medicine
Alicia Henn, Chief Scientific Officer, BioSpherix, Ltd.
Aiste Jekabsone, Researcher, Lithuanian University of Health Sciences
Pulak Nath, Technical Staff Member, Applied Modern Physics, Los Alamos National Laboratory
Terry Riss, Global Strategic Marketing Manager Cell Health, Promega Corporation
Andreas Schober, Head of Department Nano-biosystem Technology, University of Technology Ilmenau, Technische Universitat Ilmenau
Orit Shefi, Head of Neuroengineering Laboratory, Faculty of Engineering and Institute of Nanotechnologies and Advanced Materials, Bar-Ilan University Israel
Marjorie Villien, Technology & Market Analyst - Microfluidic & Medical Technologies, Yole Développement
Michael Wong, Researcher, Faculty of Health Sciences, McMaster University


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2017-07-10 00:00:002017-07-11 00:00:00Europe/LondonOrgan-on-a-Chip and 3D-Culture: Companies, Technologies and ApproachesSELECTBIOenquiries@selectbiosciences.com